UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties

Health and quality of life outcomes, 2019-04, Vol.17 (1), p.63-63, Article 63

2019

Volltextzugriff (PDF)

Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study

Clinical rheumatology, 2019-05, Vol.38 (5), p.1385-1391

2019

Volltextzugriff (PDF)

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

Arthritis research & therapy, 2011-01, Vol.13 (3), p.R94-R94

2011

Volltextzugriff (PDF)

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Annals of the Rheumatic Diseases, 2015-10, Vol.74 (10), p.1789-1798

2015

Volltextzugriff (PDF)

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Arthritis & rheumatology (Hoboken, N.J.), 2015-10, Vol.67 (10), p.2557-2568

2015

Volltextzugriff (PDF)

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Rheumatology (Oxford, England), 2019-08, Vol.58 (8), p.1344-1352

2019

Volltextzugriff (PDF)

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

The Lancet. Rheumatology, 2020-05, Vol.2 (5), p.e270-e280

2020

Volltextzugriff (PDF)

Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout

Annals of the rheumatic diseases, 2020-04, Vol.79 (4), p.536

2020

Volltextzugriff (PDF)

Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study

Clinical rheumatology, 2022-06, Vol.41 (6), p.1833-1841

2022

Volltextzugriff (PDF)

Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation

Clinical rheumatology, 2019-01, Vol.38 (1), p.263-265

2019

Volltextzugriff (PDF)

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

Clinical rheumatology, 2007-09, Vol.26 (9), p.1459-1465

2007

Volltextzugriff (PDF)

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients

Rheumatology international, 2017-09, Vol.37 (9), p.1435-1440

2017

Volltextzugriff (PDF)

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

Clinical rheumatology, 2011-02, Vol.30 (2), p.293-300

2011

Volltextzugriff (PDF)

Management of hyperuricemia in gout: focus on febuxostat

Clinical interventions in aging, 2010-01, Vol.5, p.7-18

2010

Volltextzugriff (PDF)

New advances in the treatment of gout: review of pegloticase

Therapeutics and clinical risk management, 2010-10, Vol.6, p.543-550

2010

Volltextzugriff (PDF)

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

Clinical therapeutics, 2009-08, Vol.31 (8), p.1737-1746

2009

Volltextzugriff (PDF)

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model

Journal of rheumatology, 2015-03, Vol.42 (3), p.398

2015

Volltextzugriff (PDF)

A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection

Journal of pharmaceutical and biomedical analysis, 2007-10, Vol.45 (2), p.312-317

2007

Volltextzugriff (PDF)

Leflunomide for the treatment of rheumatoid arthritis in clinical practice: Incidence and severity of hepatotoxicity

Drug safety, 2004-01, Vol.27 (5), p.345-352

2004

Volltextzugriff (PDF)

New advances in the treatment of gout: review of pegloticase

Therapeutics and clinical risk management, 2010-10, Vol.2010 (default), p.543-550

2010

Volltextzugriff (PDF)

A clinical and serological comparison of group A versus non-group A streptococcal reactive arthritis and throat culture negative cases of post-streptococcal reactive arthritis

Annals of the rheumatic diseases, 1999-07, Vol.58 (7), p.410-414

1999

Volltextzugriff (PDF)

Comparison of Cyclic Guanosine Monophosphate Response to Infusion of Atrial Natriuretic Peptide in Young and Elderly Subjects

Journal of the American Geriatrics Society (JAGS), 1993-11, Vol.41 (11), p.1241-1244

1993

Volltextzugriff (PDF)

The multidisciplinary practice guideline "The responsible use of biologicals"

Nederlands tijdschrift voor geneeskunde, 2011, Vol.155 (30-31), p.A3114

2011

Volltextzugriff (PDF)

Atrial natriuretic factor potentiates the human forearm vasoconstrictor response to sympathetic stimulation

Clinical science (1979), 1994-03, Vol.86 (3), p.275

1994

Volltextzugriff (PDF)

Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis

Clinical and experimental rheumatology, 2003-09, Vol.21 (5), p.599

2003

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(26)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(17)
Rheumatology
(17)
Female
(12)
Male
(12)
Adult
(10)
Gout
(9)
Middle Aged
(9)
Aged
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(6)
Patients
(6)
Medicine
(5)
Medicine & Public Health
(5)
Rheumatism
(5)
Antirheumatic Agents - Adverse Effects
(4)
Arthritis
(4)
Hyperuricemia
(4)
Rheumatoid Arthritis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties

Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout

Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study

Gout lessons from 2018: CARES, a direct comparison of febuxostat vs allopurinol, and CANTOS, IL1 blocker for cardiovascular risk minimisation

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients

Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature

Management of hyperuricemia in gout: focus on febuxostat

New advances in the treatment of gout: review of pegloticase

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model

A simple method for quantification of allopurinol and oxipurinol in human serum by high-performance liquid chromatography with UV-detection

Leflunomide for the treatment of rheumatoid arthritis in clinical practice: Incidence and severity of hepatotoxicity

New advances in the treatment of gout: review of pegloticase

A clinical and serological comparison of group A versus non-group A streptococcal reactive arthritis and throat culture negative cases of post-streptococcal reactive arthritis

Comparison of Cyclic Guanosine Monophosphate Response to Infusion of Atrial Natriuretic Peptide in Young and Elderly Subjects

The multidisciplinary practice guideline "The responsible use of biologicals"

Atrial natriuretic factor potentiates the human forearm vasoconstrictor response to sympathetic stimulation

Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis

Suchergebnisse filtern